US5496734A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment method for blood analysis
Assignee: Sysmex Corp
•
Filing: 1995-06-02
•
Granted: 1996-03-05
•
Expires: 2015-06-02
Abstract
Abstract The present invention is a method for blood analysis which provides a rapid treatment of a blood sample so that it can be analysed for counting and classification of leukocytes. Leukocytes are permeablized by treatment with a surfactant solution and labeled, preferably with a fluorescent dye. The method provides labeled leukocytes that can be counted and classified by optical means, including flow cytometry by analysis of a fluorescence signal.
Inventors
- 👤 Takashi Sakata
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 16:14
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; G01N33/5094; G01N15/00; G01N15/10; G01N15/14; G01N2015/1488; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10T; Y10T436/00; Y10T436/10; Y10T436/101666; Y10T436/107497; Y10T436/25; Y10T436/25125; Y10T436/2525
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
304 words
A method for classifying and counting leukocytes by an optical means which comprises; (i) treating a blood sample containing leukocytes with an aqueous solution having a pH ranging from 5.0 to 11.0 and comprising an ionic surfactant and a fluorescent dye, to give an optical difference between eosinophils and other leukocytes, wherein the ionic surfactant is used at a concentration effective to not damage the whole of the cell membrane of leukocytes in the blood sample but effective to damage a part of the cell membrane so as to allow the fluorescent dye to enter the leukocytes and stain intracellular material, and wherein said ionic surfactant is at least one selected from the group consisting of: a) a quaternary ammonium salt of the following formula: ##STR7## wherein R 1 , R 2 and R 3 are independently a hydrogen atom, a C 1 -C 8 alkyl group or a C 6 -C 8 aralkyl group; R 4 is a C 8 -C 18 alkyl group, a C 8 -C 18 alkenyl group or a C 8 -C 18 aralkyl group; and X - is an anion, b) a pyridinium salt surfactant of the following formula: ##STR8## wherein R5 is a C8-C18 alkyl group; and X - is an anion, and c) an amphoteric surfactant of the following formula: ##STR9## wherein R 6 and R 7 are independently a hydrogen atom or a C 1 -C 8 alkyl group; R 8 is a C 8 -C 18 alkyl group; and n is 1 or 2; and (II) classifying and counting the leukocytes by measuring an optical difference between eosinophils and other types of leukocytes in the blood sample based on at least two kinds of light selected from the group consisting of forward scattered light, side scattered light, red fluorescence light and green fluorescence light.
Claim 2
Independent Claim
304 words
A method for classifying and counting leukocytes by an optical means which comprises; (i) treating a blood sample containing leukocytes with an aqueous solution having a pH ranging from 5.0 to 11.0 and comprising an ionic surfactant and a fluorescent dye, to give an optical difference between eosinophils and other leukocytes, wherein the ionic surfactant is used at a concentration effective to not damage the whole of the cell membrane of leukocytes in the blood sample but effective to damage a part of the cell membrane so as to allow the fluorescent dye to enter the leukocytes and stain intracellular material, and wherein said ionic surfactant is at least one selected from the group consisting of: a) a quaternary ammonium salt of the following formula: ##STR7## wherein R 1 , R 2 and R 3 are independently a hydrogen atom, a C 1 -C 8 alkyl group or a C 6 -C 8 aralkyl group; R 4 is a C 8 -C 18 alkyl group, a C 8 -C 18 alkenyl group or a C 8 -C 18 aralkyl group; and X - is an anion, b) a pyridinium salt surfactant of the following formula: ##STR8## wherein R5 is a C8-C18 alkyl group; and X - is an anion, and c) an amphoteric surfactant of the following formula: ##STR9## wherein R 6 and R 7 are independently a hydrogen atom or a C 1 -C 8 alkyl group; R 8 is a C 8 -C 18 alkyl group; and n is 1 or 2; and (II) classifying and counting the leukocytes by measuring an optical difference between eosinophils and other types of leukocytes in the blood sample based on at least two kinds of light selected from the group consisting of forward scattered light, side scattered light, red fluorescence light and green fluorescence light.
Claim 3
Dependent Claim
20 words
A method according to claim 1, wherein one of said at least two kinds of light is side scattered light.
Claim 4
Dependent Claim
19 words
A method according to claim 1, in which a concentration of the ionic surfactant is 30 to 5000 mg/l.
Claim 5
Dependent Claim
80 words
A method according to Claim 1, in which the aqueous solution further contains at least one nonionic surfactant of the following formula: R.sub.9 R.sub.10 (CH.sub.2 CH.sub.2 O).sub.n H wherein R 9 is a C 8 -C 22 alkyl group or a C 8 -C 22 alkenyl group; R 10 is ##STR10## and n is an integer not less than 10; to give an optical difference among at least three groups of leukocytes comprising eosinophils, lymphocytes and other types of leukocytes.
Claim 6
Dependent Claim
19 words
A method according to claim 4, in which a concentration of the nonionic surfactant is 100 to 10000 mg/l.
Claim 7
Dependent Claim
45 words
A method according to claim 4, in which the aqueous solution further contains at least one water-soluble alcohol with not less than 2 carbons to give an optical difference among at least four groups of leukocytes comprising eosinophils, lymphocytes, monocytes and other types of leukocytes.
Claim 8
Dependent Claim
24 words
A method according to claim 6, in which the water-soluble alcohol is ethyl alcohol and is used at concentration of 50 to 400 ml/L.
Claim 9
Independent Claim
41 words
A method according to any one of claims 1-7, in which the aqueous solution contains a basic fluorescent dye as the fluorescent dye, and the optical difference is measured by at least one of red fluorescence light and green fluorescence light.
Claim 10
Dependent Claim
40 words
A method according to claim 8, in which the fluorescent dye is a fluorescent dye that can combine at least with cell nuclei, and is at least one dye selected from the group consisting of propidium iodide and ethidium bromide.
Claim 11
Dependent Claim
49 words
A method according to claim 8, in which the fluorescent dye is a fluorescent dye that can combine at least with cellular RNA, and is at least one dye selected from the group consisting of pyronin Y, Acridine Orange, Thiazole Orange, Acridine Orange 10 dodecyl bromide and Auramine O.
Claim 12
Dependent Claim
35 words
A method according to claim 10, in which the aqueous solution contains Acridine Orange 10 dodecyl bromide as the fluorescent dye, and the optical difference is measured based on at least the red fluorescence light.
Claim 13
Dependent Claim
27 words
A method according to claim 11, in which the fluorescent dye further contains 3,3'-dihexyloxacarbocyanine, and the optical difference is measured by at least the green fluorescence light.
Claim 14
Dependent Claim
42 words
A method according to claim 12, in which the aqueous solution further contains a sufficient amount of a salt for measuring impedance signals as electric conductivity, and further in which a difference in impedance signals is measured for counting and classifying leukocytes.
Claim 15
Independent Claim
300 words
A method of classifying and counting leukocytes by an optical means comprising; (i) treating a blood sample containing leukocytes with an aqueous solution having a pH ranging from 3.0 to 5.0 and containing an ionic surfactant, a nonionic surfactant, a water-soluble alcohol having at least two carbon atoms, and Acridine Orange 10 dodecyl bromide, to give an optical difference among groups of leukocytes comprising lymphocytes, monocytes, granulocytes and other types of leukocytes; wherein the ionic surfactant is used at a concentration effective to not damage the whole of the cell membrane of leukocytes in the blood sample but effective to damage a part of the cell membrane so as to allow the Acridine Orange 10 dodecyl bromide to enter the leukocytes and stain intracellular material and wherein the ionic surfactant is at least one quaternary ammonium salt of the following formula: ##STR11## wherein R 1 , R 2 and R 3 are independently a hydrogen atom, a C 1 -C 8 alkyl group or a C 6 -C 8 aralkyl group; R 4 is a C 8 -C 18 alkyl group, a C 8 -C 18 alkenyl group or a C 8 -C 18 aralkyl group; and X - is an anion, and wherein the nonionic surfactant is of the following formula: R.sub.9 R.sub.10 (CH.sub.2 CH.sub.2 O).sub.n H wherein R 9 is a C 8 -C 22 alkyl group or a C 8 -C 22 alkenyl group; R 10 is ##STR12## n is an integer not less than 10; and (ii) classifying and counting the leukocytes by measuring an optical difference in at least two kinds of light selected from the group consisting of forward scattered light, side scattered light, red fluorescence light and green fluorescence light among groups of leukocytes comprising lymphocytes, monocytes, granulocytes and other types of leukocytes.
Claim 16
Independent Claim
300 words
A method of classifying and counting leukocytes by an optical means comprising; (i) treating a blood sample containing leukocytes with an aqueous solution having a pH ranging from 3.0 to 5.0 and containing an ionic surfactant, a nonionic surfactant, a water-soluble alcohol having at least two carbon atoms, and Acridine Orange 10 dodecyl bromide, to give an optical difference among groups of leukocytes comprising lymphocytes, monocytes, granulocytes and other types of leukocytes; wherein the ionic surfactant is used at a concentration effective to not damage the whole of the cell membrane of leukocytes in the blood sample but effective to damage a part of the cell membrane so as to allow the Acridine Orange 10 dodecyl bromide to enter the leukocytes and stain intracellular material and wherein the ionic surfactant is at least one quaternary ammonium salt of the following formula: ##STR11## wherein R 1 , R 2 and R 3 are independently a hydrogen atom, a C 1 -C 8 alkyl group or a C 6 -C 8 aralkyl group; R 4 is a C 8 -C 18 alkyl group, a C 8 -C 18 alkenyl group or a C 8 -C 18 aralkyl group; and X - is an anion, and wherein the nonionic surfactant is of the following formula: R.sub.9 R.sub.10 (CH.sub.2 CH.sub.2 O).sub.n H wherein R 9 is a C 8 -C 22 alkyl group or a C 8 -C 22 alkenyl group; R 10 is ##STR12## n is an integer not less than 10; and (ii) classifying and counting the leukocytes by measuring an optical difference in at least two kinds of light selected from the group consisting of forward scattered light, side scattered light, red fluorescence light and green fluorescence light among groups of leukocytes comprising lymphocytes, monocytes, granulocytes and other types of leukocytes.
References Cited (Backward Citations)
US4286963A
Cited
US4962038A
Cited
US4528274A
Cited
US4751188A
Cited
US4485175A
Cited
EP0177137A2
Cited
US4745071A
Cited
US4933293A
Cited
EP0259834A2
Cited
US5296378A
Cited
US5175109A
Cited
US5039613A
Cited
US5389549A
Cited
EP0398652A1
Cited
US5250437A
Cited
US5232857A
Cited
EP0430750A1
Cited
US5242832A
Cited
EP0444241A1
Cited
EP0485945A2
Cited
US5434081A
Cited
US5256571A
Cited
US5262329A
Cited
US5264369A
Cited
US5308772A
Cited
EP0562877A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-03-05 | 1999-09-04 | 2000-03-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-03-05 | 2003-09-04 | 2004-03-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-03-05 | 2007-09-04 | 2008-03-05 | $7700.00 | Window Closed / Lapsed |